Capricor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.
CAPR Key Statistics
Stock Snapshot
Capricor(CAPR) stock is priced at $26.83, giving the company a market capitalization of 1.55B. It carries a P/E multiple of -13.14.
On 2026-06-26, Capricor(CAPR) stock moved within a range of $25.63 to $30.25. With shares now at $26.83, the stock is trading +4.7% above its intraday low and -11.3% below the session's peak.
Trading activity shows a volume of 1.02M, compared to an average daily volume of 1.26M.
Over the past 52 weeks, Capricor(CAPR) stock has traded between a high of $40.37 and a low of $4.30.
Over the past 52 weeks, Capricor(CAPR) stock has traded between a high of $40.37 and a low of $4.30.
CAPR News
Capricor Therapeutics (CAPR) announced that the Cellular, Tissue, and Gene Therapies Advisory Committee of the U.S. Food and Drug Administration is planning to...
Capricor Therapeutics (CAPR) announced five-year data from its ongoing HOPE-2 open-label extension study of Deramiocel, the company’s lead cell therapy candidat...
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.